Welcome to the ninth newsletter summarizing the latest clinical and real-world evidence in dyslipidemia and reflecting on the clinical impact of these data on dyslipidemia management.

Prof. Joana Ferreira (Portugal) summarizes three key presentations from the 25th Annual Meeting of the European Venous Forum that took place at Krakow, Poland, from 26-28 June 2025.

This session will focus on the human side of adherence, placing the patient experience at the heart of cardiometabolic care.

This session will delve into critical aspects of overcoming treatment inertia and optimizing long-term outcomes in cardiometabolic care.

This session will focus on advancing treatment outcomes and closing persistent gaps in cardiometabolic and venous disease (CMVD) care.

Leading experts will explore the close relationship between cardiometabolic and venous diseases, highlighting their shared risk factors and progression along the same clinical continuum.